Cargando…
Evaluation of the Humoral Response to Adeno-Associated Virus-Based Gene Therapy Modalities Using Total Antibody Assays
The number of viral vector-based gene therapies (GTx) continues to grow with two products (Zolgensma® and Luxturna®) approved in the USA as of March 2021. To date, the most commonly used vectors are adeno-associated virus-based (AAV). The pre-existing humoral immunity against AAV (anti-AAV antibodie...
Autores principales: | Gorovits, Boris, Azadeh, Mitra, Buchlis, George, Harrison, Travis, Havert, Mike, Jawa, Vibha, Long, Brian, McNally, Jim, Milton, Mark, Nelson, Robert, O’Dell, Mark, Richards, Karen, Vettermann, Christian, Wu, Bonnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445016/ https://www.ncbi.nlm.nih.gov/pubmed/34529177 http://dx.doi.org/10.1208/s12248-021-00628-3 |
Ejemplares similares
-
Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy
por: Gorovits, Boris, et al.
Publicado: (2023) -
Validation of Anti-Adeno Associated Virus Serotype rh10 (AAVrh.10) Total and Neutralizing Antibody Immunogenicity Assays
por: Butala-Flores, Elizabeth, et al.
Publicado: (2023) -
Accuracy of diagnostic imaging modalities for peripheral post-traumatic osteomyelitis – a systematic review of the recent literature
por: Govaert, Geertje A., et al.
Publicado: (2017) -
Adeno-Viren
por: Falke, Dietrich
Publicado: (2009) -
Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
por: Smith, Corinne J., et al.
Publicado: (2022)